trending Market Intelligence /marketintelligence/en/news-insights/trending/eonKVuloacFYsVWho72qJg2 content esgSubNav
In This List

XTL Biopharmaceuticals announces stock split

Blog

Gauging Supply Chain Risk In Volatile Times

Blog

Insight Weekly: Banks' efficiency push; vacuuming carbon; Big Pharma diversity goals

Blog

The Future of Risk Management Digitization in Credit Risk Management

Blog

Climate Credit Analytics: Diving into the model


XTL Biopharmaceuticals announces stock split

XTL Biopharmaceuticals Ltd. announced a stock split that will take effect Feb. 10.

XTL Biopharmaceuticals' depositary share will represent 100 ordinary shares of the company at that date as opposed to 20 ordinary shares previously.

The split will help the company regain compliance with Nasdaq's listing requirements.